Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sophiris Bio (SPHS)

2.17 0 (0%)

04-23 15:59

Open:

2.16

Pre. Close:

2.17

High:

2.19

Low:

2.1

Volume:

150,249

Market Cap:

63M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.193 - 2.204

2.204 - 2.214

Low:

2.073 - 2.086

2.086 - 2.097

Close:

2.148 - 2.171

2.171 - 2.19

Technical analysis  (as of: 2018-04-23 4:33:21 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 2.57     One year: 3.00

Support:

Support1: 2.05    Support2: 1.96

Resistance:

Resistance1: 2.20    Resistance2: 2.57

Pivot:

2.12

Moving Averages:

MA(5): 2.17     MA(20): 2.11

MA(100): 2.15     MA(250): 2.19

MACD:

MACD(12,26): 0.02     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 88.51     %D(3): 86.91

RSI:

RSI(14): 56.35

52-Week:

High: 2.72  Low: 1.8  Change(%): -16.5

Average Vol(K):

3-Month: 14761  10-Days 9615

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SPHS has closed below upper band by 28.3%. Bollinger Bands are 11.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-03-29T14:06:41-04:00
Sophiris Bio (SPHS) Presents At Needham and Company 17th Annual Healthcare Conference - Slideshow

2018-03-21T16:24:14-04:00
Sophiris Bio misses by $0.02

2018-03-21T16:05:00-04:00
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights

2018-03-15T16:05:00-04:00
Sophiris Bio to Present at 17th Annual Needham Healthcare Conference

2017-12-27T09:00:00-05:00
Sophiris Bio to Participate in the 10th Annual Biotech Showcase Conference

2017-12-11T08:00:00-05:00
Sophiris Bio Announces Complete Enrollment in Phase 2b Topsalysin Study of Localized Prostate Cancer

2017-11-27T08:00:00-05:00
Sophiris Bio to Participate in the 29th Annual Piper Jaffray Healthcare Conference

2017-11-09T16:05:00-05:00
Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

30.11

Shares Float (M)

30.08

% Held by Insiders

0.10

% Held by Institutions

5.50

Shares Short (K)

1730

Shares Short Prior Month (K)

2480

Stock Financials

EPS

-0.400

EPS Est. Current Year

-0.320

EPS Est. Next Year

-0.500

EPS Est. Next Quarter

-0.110

Forward EPS

-0.549

Book Value (p.s.)

8.540

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-30.3

Return on Equity (ttm)

-78.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.154

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.97

Levered Free Cash Flow (M)

-5.73

atoplab.com

Valuation

P/E

-5.43

P/E Growth Ratio

P/BV

0.25

P/S

P/CF

-6.55

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-08-15

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.